Trade RPRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Royalty Pharma plc Class A (RPRX) is trading at US$68.97, down 1.49% today as of Nov 12, 16:00 EST. The company has a market capitalisation of US$30.86B. Over the past 52 weeks, RPRX has traded between US$37.31 and US$70.37. On Syfe you can trade RPRX with $0 commission and add it to your watchlist.
| Previous close | US$70.01 |
|---|---|
| Market cap | US$30.86B |
| P/E ratio | 11.81 |
| 52-week range | US$37.31 – US$70.37 |
| Dividend yield | 1.36% |
| Volume | 3.78M |
| Exchange | US |
Royalty Pharma plc Class A
Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.
Year: 2020
Royalty Pharma Shares Fall After Novartis' Pelacarsen Fails Trial
Sep 8, 8:04 PM · MT Newswires
Royalty Pharma plc Class A (RPRX) stock is trading at US$68.97, -1.49% from the previous close of US$70.01.
The market cap for Royalty Pharma plc Class A (RPRX) stock is approximately US$30.86B.
The price-to-earnings ratio for Royalty Pharma plc Class A (RPRX) is 11.81, based on the latest reported earnings.
The 52-week high for Royalty Pharma plc Class A (RPRX) stock is US$70.37.
The 52-week low for Royalty Pharma plc Class A (RPRX) stock is US$37.31.
Yes, Royalty Pharma plc Class A (RPRX) pays a dividend. The trailing 12-month dividend yield is 1.36%.
Stay on top of RPRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
